Cannabinoids, endogenous ligands and synthetic analogs.
The investigation of natural and synthetic cannabinoid ligands, including (-)-Delta(9)-tetrahydrocannabinol, cannabinol, cannabidiol, HU-210, HU-211, CT3, CP 55, 940, WIN 55, 212-2, SR 14, 1716A, anandamide, 2-arachidonoylglycerol, and numerous novel analogs, has led to important findings that have contributed to a better understanding of the role of these compounds in physiological processes. Their potential use for medicinal purposes is also better understood as a result.
Alchem Laboratories Corporation, 13305 Rachael Boulevard, Alachua, FL 32615, USA. emilpop@aol.com
E
E
Pop
D000818:Animals; D002186:Cannabinoids / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D006801:Humans; D008024:Ligands; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000187:drug effects
D002186:Cannabinoids; D008024:Ligands; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug